A. Lu

Suitability assessment of CD24 targeted-therapy in the cancer patients with COVID-19: Preliminary results from pan-cancer

Anqian Lu, Jiantao Fu, Bin Wang, 2022, Journal of Infection.

Identification and characterization of dynamically regulated hepatitis-related genes in a concanavalin A-induced liver injury model

Yi-dong Wang, Zhejun Cai, Qianru Zhu, 2020, Aging.

BZW2/5MP1 acts as a promising target in hepatocellular carcinoma

S. Geng, Anna Chen, Guoxiong Li, 2021, Journal of Cancer.

Discovering master regulators in hepatocellular carcinoma: one novel MR, SEC14L2 inhibits cancer cells

Junping Shi, Zhihui Li, Y. Lou, 2019, Aging.

Mice models of NAFLD-related HCC

Anna Chen, Jin Yang, A. Lu, 2019, Medical Research and Innovations.

A Deep Look into the Program of Rapid Tumor Growth of Hepatocellular Carcinoma

Jianmin Lu, Anna Chen, Y. Lou, 2021, Journal of clinical and translational hepatology.

ATG101-related signature predicts prognosis and therapeutic option in hepatocellular carcinoma

Y. Lou, Anqian Lu, Jiantao Fu, 2022, Scientific Reports.